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a b s t r a c t
There is a demand to develop 3rd generation bioreﬁneries that integrate energy production with the
production of higher value chemicals from renewable feedstocks. Here, robust and stress-tolerant
industrial strains of Saccharomyces cerevisiae will be suitable production organisms. However, their
genetic manipulation is challenging, as they are usually diploid or polyploid. Therefore, there is a need to
develop more efﬁcient genetic engineering tools. We applied a CRISPR–Cas9 system for genome editing
of different industrial strains, and show simultaneous disruption of two alleles of a gene in several
unrelated strains with the efﬁciency ranging between 65% and 78%. We also achieved simultaneous
disruption and knock-in of a reporter gene, and demonstrate the applicability of the method by
designing lactic acid-producing strains in a single transformation event, where insertion of a hetero-
logous gene and disruption of two endogenous genes occurred simultaneously. Our study provides a
foundation for efﬁcient engineering of industrial yeast cell factories.
& 2015 International Metabolic Engineering Society. Published by Elsevier B.V. International Metabolic
Engineering Society. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
In addition to its traditional use in baking, brewing and wine-
making, Saccharomyces cerevisiae is an important host in industrial
biotechnology. This yeast is the host of choice for the ﬁrst and
second generation bioreﬁneries for ethanol fermentation, which
respectively use food biomass (corn starch, sugarcane) or ligno-
cellulosic feedstocks (straw, corn stover, wood). S. cerevisiae is also
applied for production of several enzymes and pharmaceutical
proteins (e.g., insulin, hepatitis and human papillomavirus vac-
cines) and it is being developed for the production of advanced
biofuels, such as farnesene and isobutanol, and ﬁne chemicals,
such as resveratrol or nootkatone (Borodina and Nielsen, 2014).
The production of fuels and chemicals in bioreﬁneries requires robust
strains, tolerant to the common stresses in the industrial setting,
such as low pH, high ethanol concentrations, ﬂuctuating tempera-
tures and the presence of various inhibitors (Demeke et al., 2013).
While there are many of such industrial strains, often adapted to
the speciﬁc environments over long-time evolution, these strains
are genetically more complex and hence less amenable to genetic
manipulation than well-studied haploid laboratory strains
(Le Borgne, 2012). Strain improvement requires several rounds of
genetic interventions, such as introduction of heterologous genes
and whole metabolic pathways, and complete or partial removal of
the activity of endogenous genes to guide the metabolic ﬂux
towards the products of interest (Li and Borodina, 2015). In
haploid laboratory strains, single genes can be disrupted and the
resulting mutants easily selected and studied. This is difﬁcult to
achieve in diploid and polyploid industrial strains exhibiting often
also aneuploidy, since multiple alleles of a gene are present and all
the copies have to be inactivated. The classical PCR-based gene
deletion strategy, based on replacement of the targeted allele with
a selection marker cassette, relies on several laborious selection
and screening processes and on the availability of an appropriate
selection marker (Wach et al., 1994). For industrial strains this
procedure is very time consuming and sometimes even infeasible.
In the past several years, new genome editing approaches
based on the use of speciﬁc endonucleases, performing double
strand breaks (DSB) and stimulating cell repair mechanisms, have
emerged and caused a breakthrough in the ﬁeld of synthetic
biology. The transcription activator-like effector nucleases
(TALENs) contain DNA-binding domain, which can be customized
to recognize any sequence of choice, and FokI endonuclease
cleavage domain (Li et al., 2011). Zinc ﬁnger nucleases (ZFNs) are
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generated by fusion of a cleavage domain and a DNA-binding zinc
ﬁnger domain. Such chimeric nucleases cleave the chromosomal
DNA in the target area and the subsequent repair via homologous
recombination (HR) or non-homologous end joining (NHEJ) results
in gene disruption or another desired change in the affected
genome (Urnov et al., 2010).
More recently, an alternative genome editing approach clusters
of regularly interspaced palindromic repeats–CRISPR-associated
nuclease 9 (CRISPR–Cas9), based on RNA-guided nuclease activity,
emerged (Cong et al., 2013; Mali et al., 2013). Streptococcus
pyogenes Cas9 endonuclease is originally a part of the bacterial
immune system, where it forms ribonucleoprotein complex with
two small RNA molecules and performs sequence-speciﬁc cleavage
of the invading DNA (Horvath and Barrangou, 2010). So called
CRISPR (cr) RNA is transcribed from the genome-encoded clusters
of foreign DNA, processed and annealed to trans-activating (tracr)
RNA molecule. Such complex then guides Cas9 to the target
sequence (Gasiunas et al., 2012). It has been shown that target
recognition by Cas9 requires a 20-bp sequence within crRNA,
which base pairs with the target genomic sequence and a NGG
trinucleotide, called protospacer adjacent motif (PAM), immedi-
ately downstream the target sequence. The parts of tracrRNA and
crRNA, essential for Cas9 activity, can be combined into a single
chimeric guide molecule (gRNA) with a target sequence on its 50
end. By redesigning the 50 end of the gRNA molecule the system
can be programmed to target any desired sequence (Jinek et al.,
2012). This represents a great advantage compared to TALENs and
ZFNs, which are generally very time-consuming and costly to
design. Several studies demonstrating the use of CRISPR–Cas9-
mediated genome editing, such as single and multiplex gene
disruptions and targeted insertions have been reported in bacteria
(Bikard et al., 2013), human cells (Mali et al., 2013), mice (Cong et
al., 2013), ﬂies (Gratz et al., 2013) or worms (Dickinson et al., 2013).
DiCarlo et al. (2013) have demonstrated efﬁcient single gene
disruptions in haploid S. cerevisiae cells, engineered with
CRISPR–Cas9, when the donor template for homology directed
repair (HDR) of the double strand break was co-transformed.
Recently, simultaneous multiple gene disruptions in yeast have
been reported (Bao et al., 2014), even in polyploid strain (Ryan et
al., 2014).
In this study, we address the questions whether CRISPR–Cas9
method is suitable for engineering of strains isolated from various
industrial settings and if there are potential limitations based on
lower genetic accessibility of such strains. We also aim at showing
whether these can be easily engineered for production of valuable
chemicals. We demonstrate that a CRISPR–Cas9 genome editing
tool can be used for efﬁcient disruption of multiple alleles of the
genes and for DNA insertion without speciﬁc adjustments, in
several unrelated industrial strains. Firstly, we develop and test
the method using the ADE2 gene as the disruption target and
green ﬂuorescent protein (GFP) as insertion fragment for simulta-
neous disruption and knock-in. Secondly, we demonstrate the
applicability of the CRISPR–Cas9 method by single-step construc-
tion of lactate-producing yeast, where both alleles of PDC1 and
PDC5 genes are disrupted and heterologous lactate dehydrogenase
genes are inserted. Furthermore, we show that it is important to
consider potential off-target effects of the system, despite their
relatively low frequency.
2. Materials and methods
2.1. Strains and cultivation conditions
The S. cerevisiae strains used in this study are listed in Table 1.
Yeast cells were grown at 30 1C in standard yeast peptone dextrose
(YPD) medium supplemented with 20 g/l agar for preparation of
solid medium. For cultivation of pdc1Δpdc5Δ strains, the glucose
was replaced by 20 g/l ethanol or deﬁned mineral medium (Jensen
et al., 2014) containing 10 g/l glucose and 1 g/l sodium acetate was
used. For selection, the media were supplemented with 200 mg/l
G418 sulfate, 200 mg/l hygromycin B, or 100 mg/l nourseothricin.
For selection on acetamide, conditions described in Solis-Escalante
et al. (2013) were adopted. To examine sporulation capability, the
strains were grown overnight on pre-sporulation plates (20 g/l
yeast extract, 30 g/l nutrient broth, 50 g/l glucose, 20 g/l agar),
subsequently inoculated on sporulation plates (10 g/l potassium
acetate, 50 mg/l zinc acetate, 10 mg/l adenine, 20 g/l agar) and
incubated for 4 days at room temperature. Escherichia coli strain
DH5α was used as a host for cloning procedures and plasmid
propagation. E. coli cells were grown at 37 1C in Lucia–Bertani (LB)
medium containing 100 mg/l ampicillin.
2.2. Spore and GFP ﬂuorescence evaluation
Spores were observed under Zeiss Primo Star transmitted-light
bright-ﬁeld microscope. After 1-h digestion of spore wall in
2.5 mg/ml solution of Glucanex (Sigma-Aldrich), the tetrads were
dropped on YPD plates. Tetrad dissection was performed under
Zeiss Axio Scope.A1 dissection microscope and the spores were
grown for 2 days. Screening of ﬂuorescent protein-expressing
colonies was performed by visual scoring using the Safe Imager
benchtop blue light transilluminator (Invitrogen). Measurement of
GFP ﬂuorescence was carried out in Cornings black ﬂat-bottom
96-well microtiter plates using Biotek Synergy MX multi-mode
plate reader in 485/512 nm emission/excitation wavelength.
2.3. Cloning and strain construction
The plasmids with dominant selection markers were con-
structed using USER fusion (Nour-Eldin et al., 2010)
(Supplementary Table 1). The biobricks were ampliﬁed by PCR
with PfuX7 polymerase (Nørholm, 2010) under the following
conditions: 98 1C for 2 min, 30 cycles of 98 1C for 10 s, 54 1C for
10 s, 72 1C for 30 s/1 kb, 72 1C for 10 min. The used primers and
templates are listed in Supplementary Tables 1 and 2. The
dominant marker gene cassettes were synthesized by GeneArt
(Life Technologies). DNA fragments were gel puriﬁed and incu-
bated in HF buffer (New England Biolabs) together with USER
enzyme (New England Biolabs) for 25 min at 37 1C followed by
incubation at 25 1C for 25 min. Completed reactions were trans-
formed into chemically competent E. coli cells. Synthetized GFP
gene was provided by Morten Nørholm (Technical University of
Denmark) (Toddo et al., 2012). Synthetized L-lactate dehydrogen-
ase gene (ldhL) from Lactobacillus plantarum (Supplementary File
1) was ﬁrstly digested with KpnI and SalI restriction endonucleases
and ligated into plasmid pE1 (Borodina et al., 2015), digested
with the same enzyme pair. GFP gene, ldhL gene and Streptococcus
pyogenes Cas9 gene (DiCarlo et al., 2013) were PCR ampliﬁed
and inserted along with TEF1 promoter into integrative plas-
mids by USER cloning (Jensen et al., 2014). Parental vectors
(Supplementary Table 1) were digested with AsiSI endonuclease
and subsequently nicked with Nb.BsmI and assembled with
desired biobricks as described above. The integrative vectors were
linearized with NotI restriction endonuclease before yeast trans-
formation. To construct the plasmids with speciﬁc gRNA cassettes,
we PCR-ampliﬁed the whole plasmid with phosphorylated pri-
mers, containing the desired target sequences on their 50 end. For
this reaction we used Phusion Hot Start II DNA polymerase
(Thermo Scientiﬁc). The PCR product was subsequently self-
circularized using T4 DNA ligase (Thermo Scientiﬁc) according
to manufacturer's protocol and treated with DpnI endonuclease.
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For homologous recombination-mediated gene replacement, the
disruption cassettes were prepared by PCR (Reid et al., 2002). One
cassette consisted of the upstream ADE2 region and the ﬁrst 2/3
part of kanMX marker, and the other cassette contained the last 2/
3 part of kanMX marker and the downstream sequence of ADE2.
Both fragments were made by fusion PCR (Yon and Fried, 1989)
and then simultaneously transformed to yeast cells. 90-bp dsDNA
oligos (Supplementary Table 2) used as template for DSB repair
were synthesized by Integrated DNA Technologies. Gene-carrying
fragments, such as GFP or ldhL expression cassettes, used alter-
natively as DSB repair templates, were prepared with primers
containing 40-bp overhangs to particular genomic sequence bor-
dering potential Cas9 cutting site and integrative plasmids
(Supplementary Table 1) as templates.
2.4. Yeast transformation
Yeast cells were transformed by PEG/LiAc method according to
Gietz and Woods (2006). The heat shock time was prolonged to
90 min for strain CBS7960 in order to get higher transformation
efﬁciency.
2.5. Propidium iodide staining and ﬂow cytometer analysis
Yeast cells were grown in cell culture tubes in 1 ml YPD for
2 days with shaking (200 rpm). The cells were collected by
centrifugation, washed in 1xSSC buffer (150 mM sodium chloride,
15 mM sodium citrate; pH¼7), resuspended in 1 SSC/70%
ethanol solution and stored at 20 1C overnight. The ﬁxed cells
were centrifuged, resuspended in 1 SSC buffer with 0.25 mg/ml
RNase A and treated overnight at 37 1C. The samples were then
treated with 1 mg/ml proteinase K for 1 h at 37 1C. The cells were
collected and stained in 1 SSCþ10 μg/ml propidium iodide (PI)
for 1 h at room temperature in the dark. The stained cells were
stored at 4 1C until analysis. The samples were brieﬂy sonicated
and analyzed with BD LSRFortessa cell analyzer equipped with
blue 488-nm laser (50 mW power) and 695/40-nm bandpass ﬁlter.
Histograms were acquired in linear mode. The data was analyzed
with BD FACSDiva software.
2.6. HPLC analysis
Concentrations of lactic acid, glucose, pyruvic acid, ethanol,
acetate, succinate and glycerol in culture supernatants were
determined by HPLC (UltiMate 3000, Dionex). The samples were
analyzed for 30 min using Aminex HPX-87H ion exclusion column
with a 5 mM H2SO4 ﬂow of 0.6 ml/min. The temperature of the
column was 60 1C. The refractive index at 45 1C and the UV
absorption at 210 nm were measured. Glucose, lactic acid, glycerol
and ethanol were detected using RI-101 Refractive Index Detector
(Dionex). Pyruvate, succinate and acetate were detected with
DAD-3000 Diode Array Detector at 210 nm (Dionex). The data
was acquired and analyzed with Chromeleon software.
3. Results and discussion
3.1. Assessment of ploidy of the industrial strains CBS7960 and
CLIB382
Industrial strains Ethanol Red, which is a commercial strain
commonly used in many ﬁrst generation ethanol plants, CBS7960
Brazilian ethanol producer from sugar-cane syrup and an Irish
brewer's strain CLIB382, isolated from super-attenuated beer, were
included in this study (Table 1). As a representative of an easily
accessible and well-deﬁned laboratory strain, CEN.PK113-7D was
chosen. This strain is widely used for metabolic engineering and as
a reference strain in systems biology and functional genomics
studies (Daran-Lapujade et al., 2003; Canelas et al., 2010). To
estimate the ploidy of the industrial strains, we determined the
relative DNA content of the cells stained with propidium iodide by
ﬂow cytometry. Based on this analysis, all the chosen industrial
strains were assessed as diploids when compared to the known
haploid DNA content of CEN.PK strain (Fig. 1).
3.2. Construction of tools for Cas9-mediated genetic manipulation in
industrial yeast
To perform Cas9-mediated genome editing in industrial yeast
strains an approach, developed by DiCarlo et al. (2013), was
adapted. The system uses S. pyogenes Cas9 nuclease-encoding
gene, codon-optimized for yeast, and a single chimeric gRNA,
which carries the 20-bp target sequence, and the structural
module essential for Cas9 activity (Jinek et al., 2012). The gRNA
molecule is transcribed from the expression cassette containing
regulatory elements of RNA polymerase III (DiCarlo et al., 2013).
For use in prototrophic yeast strains, a replicative (CEN/ARS
element containing) vector carrying Cas9 gene with dominant
kanMX selection marker and 2μ-replicative vector carrying gRNA
molecule with dominant natMX selection marker were prepared
(Fig. 2A). Speciﬁc sequence on the 50 end of the gRNA molecule,
targeting a gene of interest (GOI), was introduced on the primer
used for ampliﬁcation of the entire plasmid, allowing easy and
cost-effective generation of gRNA targeting vector by PCR and
ligation, followed by E. coli transformation (Fig. 2A). The suitable
target sequence was selected using CRISPy online Internet tool
(Ronda et al., 2014), which was adapted to the CEN.PK genome
sequence (Jakočiu̅nas et al., 2015). The criteria for the selection
were: minimal off-target effects elsewhere in the genome, proxi-
mity to the N-terminus of the coding region of the gene, and
conserved sequence in order to target the gene in various
unrelated strains. To achieve the maximal efﬁciency of disruption,
a 90-bp dsDNA donor oligo was designed. The oligo would
introduce a STOP codon into the PAM sequence behind the target
site of a gene of interest upon a homologous recombination
(Fig. 2B). Some other single nucleotide changes in the “seed”
sequence of gRNA target sequence (Jinek et al., 2012) and frame-
shift mutation behind the introduced STOP codon were also
included.
Table 1
List of strains used in the study.
Strain Ploidy Description Source
CEN.PK113-7D (MATa) Haploid Laboratory strain Peter Kötter, Johann Wolfgang Goethe University Frankfurt
CBS7960 Diploida Brasilian bioethanol producer from cane-sugar syrup Silas Villas-Bôas, University of Auckland
CLIB382 Diploida Irish brewer's strain Silas Villas-Bôas, University of Auckland
Ethanol Red (MATa/α) Diploid Industrial bioethanol producer Fermentis (A Lesaffre division)
a Determined in this study using ﬂow cytometry analysis of the DNA content.
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3.3. Disruption of ADE2 in industrial strains
To analyze the suitability and efﬁciency of CRISPR–Cas9 as a
tool for gene disruption in various industrial strains, a proof-of-
concept in the form of Cas9-mediated ADE2 gene disruption was
selected (Fig. 3A). ADE2 encodes phosphoribosylaminoimidazole
carboxylase, which catalyzes a step in the de novo purine nucleo-
tide biosynthetic pathway. The ade2Δ mutant phenotype can be
recognized by red color of the colonies, since the mutant cells,
deprived of adenine, accumulate red purine precursors in the
vacuole (Ugolini and Bruschi, 1996). As a control experiment,
single-allele replacement by PCR-generated marker cassette was
performed in haploid CEN.PK and in diploid Ethanol Red strain. As
expected, the red mutant colonies were observed only in the case
of haploid CEN.PK, as in the Ethanol Red only one of the two ADE2
alleles was disrupted (Fig. 3B). As expected, the phenotype of
Ethanol Red ade2Δ: kanMX/ADE2 strain did not differ from the
phenotype of parental Ethanol Red strain revealing that elimina-
tion of both alleles must be performed to achieve mutant pheno-
type. Using the CRISPR–Cas9 system, the cells, expressing Cas9
gene either from a replicative plasmid or from a genomic location,
were transformed with a 2μ-replicative vector, carrying the gRNA
molecule along with templates for DSB repair and selected for
presence of both markers. High efﬁciency of ADE2 disruption was
observed in all strains reaching the values of 95%, 65%, 78% and
66% in CEN.PK, Ethanol Red, CBS7960 and CLIB382, respectively
(Fig. 3C and D). This shows that using the two plasmid system,
which (probably due to insufﬁcient expression of a guiding RNA
component) resulted in the method inefﬁciency in previous study
(Bao et al., 2014), high disruption efﬁciency can be achieved.
Furthermore, the presented system allows for high disruption
efﬁciency in several unrelated industrial strains, when no further
adjustments in terms of gRNA expression, which have been
reported recently (Ryan et al., 2014), are needed. The simplicity
of a gRNA plasmid generation allows for fast evaluation of the
disruption efﬁciency of any gene of interest without synthetic and
cloning procedures.
The gRNA plasmid transformation efﬁciency was lower in the
case of strains expressing Cas9, when compared to the wild type
cells. This negative effect was more pronounced in those indus-
trial strains that have generally lower transformation efﬁciency
(Supplementary Fig. 1) and also when Cas9 was expressed from
genomic location rather than from an episomal vector (not
shown). The decreased transformation efﬁciency was also
observed in laboratory strains expressing Cas9 and could be
explained by the toxicity caused by off-target effects of the
CRISPR–Cas9 system (DiCarlo et al., 2013). It has been shown that
high level of Cas9 expression itself from a 2μ-based vector
decreases the ﬁtness of the cells and needs to be balanced (Ryan
et al., 2014). However, the growth of the strains was not in any way
affected by Cas9 carried alone on a low copy number vector
(Fig. 2A), even under control of the strong TEF1 promoter (not
shown). It therefore appears reasonable to maintain Cas9 expres-
sion relatively low and stable while keeping the expression of
gRNA high (e.g., by using a 2μ vector; Fig. 2A) to ensure high
editing efﬁciency. Yet, the low transformation efﬁciency of Cas9-
expressing strains could be a limiting factor, when some hardly
accessible strains are considered to be engineered. We addressed
this limitation by further decreasing Cas9 expression by using a
weaker promoter (ADH1) (Fig. 2A). With this setup, the yield of
transformants was signiﬁcantly higher, and even in case of
CBS7960 strain, exhibiting generally low transformation efﬁciency,
we obtained ﬁve times more transformants (Supplementary
Fig. 1). At the same time, the gene disruption efﬁciency was
similar as before (Fig. 3D). When the dsDNA oligo was omitted,
surprisingly high frequency of up to 16% of ade2Δ mutants was
observed in CEN.PK strain. The disruption efﬁciency was much
lower, but still signiﬁcant in Ethanol Red and CLIB382 strains
(around 3%) and not evaluated in strain and CBS7960 strain due to
low number of positive transformants (Fig. 3D). This is in contrast
with the previous ﬁndings, where the frequency of mutation in the
absence of donor DNA was only around 0.1% (DiCarlo et al., 2013).
Omission of the donor dsDNA also had further negative effect on
the transformation efﬁciency as shown also previously (DiCarlo et
al., 2013) (Supplementary Fig. 1). The negative controls, when the
gRNA vector was omitted and only dsDNA was introduced, did not
yield any mutant colonies among several thousand clones
observed.
The affected parts of the ADE2 gene were sequenced in a few
randomly selected clones of CEN.PK and Ethanol Red strains. The
majority of the red colonies, resulting from transformation with
gRNA and donor dsDNA, contained the desired premature STOP
codon (Supplementary Fig. 2). A few clones of CEN.PK also
contained indel-caused frame-shift mutations. This signals that
the DSB was repaired in other way than the homologous recom-
bination with the donor dsDNA oligo. Mainly in case of Ethanol
Red, where the proportion of non-mutant colonies is higher, some
of the white colonies contained substitute mutations introduced
with dsDNA donor in the expected cleavage region, but without
the premature stop codon. Here, we did not observe any other
random sequence changes, such as insertions or deletions, eviden-
cing repair by NHEJ. This reveals that the DSB had occurred, the
repair template had been delivered into the cells, but not entire
donor sequence was inserted. The mutant clones, obtained by
transformation with gRNA plasmid only, contained exclusively
frame-shift mutations (Supplementary Fig. 2).
3.4. Simultaneous disruption of ADE2 and knock-in of GFP in
industrial strains
To evaluate the possibility of simultaneous gene disruption and
knock-in, we generated a DNA knock-in cassette, containing GFP-
coding gene under control of TEF1 promoter. The cassette had 40-
bp ﬂanking sequences, homologous to the genome targeting
region (Fig. 2B). The cassette was co-transformed along with the
ADE2-targeting gRNA plasmid into Cas9-expressing cells of CEN.PK
and Ethanol Red, CBS7960 and CLIB382 strains instead of the
Fig. 1. Determination of strain ploidy. Uniparametric histogram shows distribution
of PI stained cells according to their relative DNA content as examined by ﬂow
cytometry. CEN.PK113-7D strain of known ploidy was included as a reference.
Individual histograms overlaid with 1N (haploid) CEN.PK histogram for comparison
are included at the upper part of the picture. First peak represents population of
G1-phase cells, second peak population of G2-phase cells.
V. Stovicek et al. / Metabolic Engineering Communications 2 (2015) 13–2216
donor dsDNA oligo (Fig. 3A). The efﬁciency of disruption (occur-
rence of red colonies) was comparable to the efﬁciency obtained
with donor dsDNA oligo, when 10 μg of the knock-in cassette were
used and signiﬁcantly increased (reaching values of 97%, 82%, 92%
and 81% in CEN.PK, Ethanol Red, CBS7960 and CLIB382, respec-
tively) when increased amounts of gRNA plasmid (3 μg) and the
repair cassette (15 μg) were used (Fig. 3D). This strongly suggests
that when a gRNA vector and the appropriate repair DNA template
are delivered into the cells, the presented system does not appear
to have any other signiﬁcant limitations. Bao et al. (2014) reported
a way to facilitate the delivery of the donor DNA template by
harboring it in the spacer of the crRNA array on plasmid. However,
this system has limitations in the length of the sequence, which
can be cloned as a HDR template, and apparently cannot be used
for insertions of larger (heterologous) gene cassettes (Bao et al.,
2014).
To uncover the number of GFP copies inserted in the genome
of haploid and diploid strains, we performed measurement of
GFP ﬂuorescence of cell populations of randomly selected GFP-
positive ade2Δ clones CEN.PK (1 N) and Ethanol Red (2 N) strains,
cultivated in mineral medium supplemented with adenine. Addi-
tionally, we evaluated haploid populations, derived from the four
spores of ten red ﬂuorescent Ethanol Red clones. All the haploid
spores showed ade2Δ phenotype and GFP ﬂuorescence, which was
comparable to the level of ﬂuorescence of haploid CEN.PK clones
and approximately twice lower than GFP ﬂuorescence of parental
diploid cells (Supplementary Fig. 3). This reveals that all the tested
diploid cells contained homozygous insertions of the reporter
gene. Furthermore, the number of clones, exhibiting GFP ﬂuores-
cence, was evaluated. Between 45% and 52% of the mutant red
colonies of all strains showed GFP ﬂuorescence (Fig. 3D). Success-
ful Cas9-mediated insertion of heterologous marker gene cassette
was achieved in laboratory strain and one polyploid strain, but
only when different (tRNA-based) promoters driving expression of
gRNA molecule were used (Ryan et al., 2014). PCR and sequence
analysis of the ADE2 gene of several non-ﬂuorescent red CEN.PK
and Ethanol Red clones showed that in most cases the expression
cassette was not entirely inserted. Instead, different parts of the
template DNA were used for DSB repair resulting in disruption of
ADE2 but not in expression of the reporter gene. This is consistent
Fig. 2. Tools for Cas9-mediated genome editing in industrial strains. (A) Schematic illustration of replicative (CEN/ARS containing) plasmid carrying Cas9 gene, controlled by
TEF1 (or ADH1) promoter, and kanMX marker for selection. Alternatively, insertion of PTEF1-Cas9 into the genome using integrative plasmid (not displayed) was performed.
The vector with TEF1 promoter controlling Cas9 expression was used unless otherwise stated. The two-micron-based replicative plasmid contains the gRNA expression
cassette and natMX dominant marker for selection. The detailed illustration of gRNA cassette is displayed below the plasmid maps, including design of phosphorylated
(P) primers used for PCR ampliﬁcation of the plasmid with forward primer containing speciﬁc 20-bp target sequence (TS). (B) Illustration of target site of a gene of interest
(GOI) in the genome, Cas9 target site being part of gRNA sequence and followed by PAM motif is highlighted. Templates, 90-bp dsDNA oligo introducing STOP codon into the
coding sequence (1) and a gene expression cassette disrupting the coding sequence (2), used for DSB repair are displayed below.
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with previous experiments when 90-bp dsDNA donor was used as
repair template. There, a desired stop codon was introduced but
not the other single nucleotide changes (SNPs) the template
contained. In some Ethanol Red clones, even the introduction of
premature stop codon sometimes did not occur meanwhile the
other SNPs appeared (Supplementary Fig. 2). However, some CEN.
PK red and non-ﬂuorescent clones contained indel mutations. This
reveals that such cells probably did not gain the donor DNA
template and the double strand break was repaired by NHEJ or
other kind of error-prone mechanisms (Daley et al., 2005). Sur-
prisingly, a few of the white colonies expressed GFP. Some of them
contained the PTEF1-GFP cassette in the appropriate location
disrupting ADE2, suggesting, at least in case of haploid CEN.PK
strain, reversion to Adeþ phenotype by the suppression of the
ade2Δmutation (Achilli et al., 2004). On the other hand, few clones
contained the GFP gene integrated somewhere else, leaving the
ADE2 gene intact. As random insertion of the cassette not coupled
with any selection is highly improbable and could not be detected
in the control experiments, the wrong integration may be caused
by off-target effects of CRISPR–Cas9 system, which have also been
reported in other organisms (Hsu et al., 2013; Fu et al., 2013).
Relatively low off-target change occurrence reveals that such
effects can hardly be noticed, when only few clones are sequenced
as in Ryan et al. (2014). Thus, the possibility of the off-target effect
should always be taken into account when designing the gRNA
molecule (Cho et al., 2013).
Fig. 3. Disruption of ADE2 gene – proof-of concept. (A) Illustration of Cas9-mediated genomic changes in ADE2 coding sequence. Introduction of STOP codon into coding
sequence of ADE2 gene in haploid – 1n and diploid – 2n cells, left; disruption of ADE2 sequence with PTEF1-GFP expression cassette, right. (B) Colonies of the strains with
single-allele ADE2 disruption performed with PCR-generated marker cassette disruption. Red color of the colony represents ade2Δ phenotype. (C) Colonies of the Cas9-
expressing strains selected for presence of gRNA plasmid, being transformed along with 1 nmol/μl 90-bp dsDNA donor. (D) Disruption frequency of ADE2 gene (number of
red colonies per total number of transformants selected for presence of both Cas9-carrying and gRNA-carrying vectors) in analyzed strains. Black columns show the mutation
frequency when dsDNA oligo donor is used as a repair template and Cas9 expression is driven by TEF1 promoter, dashed columns represent the situation when Cas9
expression is driven by ADH1 promoter, gray columns show the mutation frequency when 15 μg of PTEF1-GFP cassette is used instead of dsDNA oligo donor and white
columns represent the case when any repair template is omitted. Green pattern columns show percentage of ﬂuorescent clones among ade2Δ mutants. Error bars represent
standard deviation (SD, N¼3 or N¼2 in case of ADH1p-Cas9 experiment).
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The disruption frequency is apparently dependent on the strain
background due to different HDR-mediated repair activity of the
particular strain and correct insertion of DNA donor. The latter
explains the different disruption efﬁciencies obtained in experi-
ments using either dsDNA oligo or a gene expression cassette as
repair templates. When larger DNA cassette as a repair template is
introduced, it always leads to the disruption of a gene, even if the
cassette is not entirely inserted. In case of the donor dsDNA oligo,
the premature STOP codon is not incorporated in some cases,
resulting in lower efﬁciency. However, the efﬁciency of the
presented system appears to be high enough to execute simulta-
neous disruption and knock-in of a heterologous gene expression
cassette in three genetically complex strains. The presented two
plasmid setup keeps low and stable expression of Cas9 to avoid
any potential undesired sequence changes caused by its imbal-
anced expression, and high (SNR52 promoter driven) expression of
a gRNA molecule. In future, feasibility of targeting multiple genes
in different industrial strains by simultaneous expression of multi-
ple gRNAs at the same time by the approaches reported recently
(Bao et al., 2014; Ryan et al., 2014) will be an attractive task.
3.5. Efﬁcient removal of CRISPR–Cas9 tools results in stable marker-
free genome alterations
An advantage of the CRISPR–Cas9 editing approach is that no
selection marker is supposed to be left in the genome of the
engineered strains since the plasmids, used for execution of the
desired changes, can be cured out of the cells. To demonstrate the
stability of introduced changes and marker-free nature of the
method, we streaked few GFP expressing ade2Δ clones of both
CEN.PK and Ethanol Red strains and grew them overnight on non-
selective YPD plates. Several hundred cells were then plated on
YPD plates. All the colonies maintained their original phenotype,
i.e. they were red and showed comparable level of GFP ﬂuores-
cence. The colonies were replica-plated on fresh YPD plates
supplemented with either G418 or nourseothricin, and around
50% and 60% of CEN.PK and Ethanol Red cells, respectively, lost
CEN/ARS Cas9-carrying plasmid. The gRNA 2μ-based plasmid was
lost in the majority of cells resulting in stable marker-free
phenotype (Supplementary Fig. 4). Keeping the selection, the
Cas9-carrying vector can be maintained in the cells without any
impact on cell ﬁtness (Section 3.3), while the 2μ vector can be
easily replaced by another gRNA vector targeting another gene of
interest. This represents a remarkable advantage when compared
to laborious approaches requiring marker insertion and subse-
quent particular marker recycling strategy (Guldener et al., 1996).
3.6. Disruption of pyruvate decarboxylase genes PDC1 and PDC5 in
an industrial strain
To demonstrate the use of the CRISPR–Cas9 genome editing
tool for metabolic engineering, we decided to engineer CEN.PK
and industrial Ethanol Red strain for production of the industrially
important chemical L-lactic acid (Borodina and Nielsen, 2014).
Several studies describing strategies for engineering of yeast
strains for lactate production have been reported (Ishida et al.,
2006; Van Maris et al., 2004a). These involve attenuation or
elimination of pyruvate decarboxylase activity, transforming pyr-
uvate to acetaldehyde, which is subsequently transformed to
ethanol (Pronk et al., 1996), and expression of heterologous lactate
dehydrogenase for conversion of pyruvic acid to lactic acid (Porro
et al., 1995). S. cerevisiae contains three pyruvate decarboxylase
isoenzymes, where the major isoforms are Pdc1p and Pdc5p
(Flikweert et al., 1996). Disruption of PDC1 and PDC5 has pre-
viously been shown to result in inability of the strains to grow on
glucose as the sole carbon source (Pronk et al., 1996), most likely
due to redox co-factor imbalance, and dependence on C2-carbon
sources for generation of cytoplasmic acetyl-CoA, needed for lipids
biosynthesis. To balance NADH overproduction in the pdc1Δpdc5Δ
strains, we ﬁrst introduced L. plantarum L-lactate dehydrogenase
(ldhL) gene into the genomes of Cas9-expressing CEN.PK and
Ethanol Red strains. The resulting strains did not produce lactic
acid under aerobic conditions (data not shown). Subsequently, the
Pdc1/Pdc5 phenotype was introduced (Fig. 4A). As the homol-
ogy of PDC1 and PDC5 genes is 95%, we designed a single gRNA for
targeting both genes. The donor dsDNA oligo was designed to
introduce a premature stop codon into PDC1 and PDC5 sequences
(Fig. 4A). The ldhL- and Cas9-containing yeast strains were co-
transformed with PDC-targeting gRNA and the donor dsDNA oligo.
The resulting transformants were analyzed by PCR and sequencing
of the targeted PDC1 and PDC5 loci (Supplementary Fig. 5). Seven
out of the ten analyzed CEN.PK clones contained disruption
mutations in all PDC1 and PDC5 alleles, with one of them contain-
ing frame-shift indel mutation and the rest STOP codons. For
Ethanol Red strain, nine of the twenty ﬁve tested clones contained
the desired mutations in both PDC1 and PDC5 genes. Several of the
clones contained substitute mutations along the potential cleavage
site, revealing improper integration of the dsDNA donor
(Supplementary Fig. 5). All the clones veriﬁed for the presence of
pdc1Δpdc5Δ mutations were grown aerobically on mineral med-
ium with 10 g/l of glucose supplemented with 1 g/l of acetate and
the concentration of lactate in the fermentation broth was ana-
lyzed by HPLC. While all seven CEN.PK derived strains produced
certain amount of lactic acid, two out of nine of the Ethanol Red
derived clones did not produce any lactic acid suggesting hetero-
zygosity in one or both PDC alleles not uncovered by sequencing or
suppression of their mutations. Selected CEN.PK and Ethanol Red
lactate-producers were inoculated to initial OD¼0.1 from over-
night culture and cultivated aerobically in mineral medium
in deep-well plates for 5 days. Production of metabolites, as
analyzed by HPLC, and growth properties were determined in a
time-course experiment (Fig. 4B). Both strains exhibited much
slower growth and glucose consumption when compared to the
parent strains, which depleted the carbon sources in the cultiva-
tion medium in 24 h (including produced ethanol) in case of
CEN.PK or even faster in case of Ethanol Red (data not shown).
Lactate-producer, derived from CEN.PK strain, grew even slower
when compared to its Ethanol Red counterpart. Expectedly, the
glucose consumption was more efﬁcient in case of the engineered
Ethanol Red. After 100 h of cultivation, the residual glucose
concentration was 1.2570.6 g/l and 4.0870.08 g/l of glucose in
Ethanol Red and CEN.PK, respectively. However, the ﬁnal titer of
lactic acid was 2.7470.11 g/l in CEN.PK and 2.5270.03 g/l in
Ethanol Red resulting in yield of 0.6170.05 g and 0.3570.03 g
lactic acid per 1 g consumed glucose, respectively. This conﬁrms
that lactic acid yields are also strongly dependent on the strain
background (Branduardi et al., 2006). Expectedly, the achieved
lactic acid titers were low due to the low glucose consumption
by Pdc1/Pdc5 cells. The strain performance could be improved
by adaptive laboratory evolution, as has been shown in the
previous studies (Van Maris et al., 2004a; Van Maris et al.,
2004b), but this was not the scope of this paper. Production
of pyruvate was slightly higher in Ethanol Red derivative and
there was no (Ethanol Red) or very low (CEN.PK) production of
ethanol (Fig. 4B). Acetate concentration remained more or less at
the initial concentration when CEN.PK lactate-producer was
examined, revealing no signiﬁcant production or consumption
during the time-course, whereas signiﬁcant drop in acetate con-
centration occurred in Ethanol Red strain (Fig. 4B). As for the other
metabolites, glycerol and succinate levels were very low not
exceeding concentrations of 0.08 g/l in CEN.PK strain and 0.16 g/l
in Ethanol Red.
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3.7. Simultaneous disruption of pyruvate decarboxylase genes PDC1
and PDC5 and knock-in of lactate dehydrogenase in an industrial
strain
To demonstrate one-step generation of lactic acid producing
strains we constructed ldhL expression cassette ﬂanked with 40-
bp homologous region designed to disrupt PDC1 and PDC5 genes
and transformed the cassette together with gRNA plasmid to Cas9-
expressing cells (Fig. 4A). Mutant strains veriﬁed for presence of
ldhL gene inside PDC1 and PDC5 coding sequence, were cultivated
as described before and supernatant analyzed by HPLC. Since
the growth of both CEN.PK and Ethanol Red lactate-producing
derivatives was affected even more when compared to their two-
step procedure created counterparts (Section 3.6), cells were
inoculated to higher initial OD¼0.5. The growth defect might be
caused by lower expression level of ldhL and NADH accumulation.
The expression level might have been inﬂuenced by insertion of
the ldhL gene inside the coding region of PDC genes, instead of
insertion to a veriﬁed insertion site performed before (Section 3.6),
providing high level of expression of a heterologous gene (Jensen
et al., 2014). The slow growth was accompanied with slow glucose
consumption and also lower lactic acid production in CEN.PK
strain resulting in titer of 1.4770.13 g/l when only 3.670.19 g of
glucose was consumed. In case of Ethanol Red, the growth and
Fig. 4. Construction of lactic acid producing yeast strains. (A) Illustration of one-step Cas9-mediated PDC1 and PDC5 gene disruption in strains containing ldhL gene inserted
in chromosome X, left; and PDC1 and PDC5 disruption by PTEF1-ldhL expression cassette, right. Haploid strain – 1n, diploid strain – 2n. (B) Time-course metabolite proﬁle
(lactic acid – closed triangles, glucose – closed diamonds, pyruvate – dashed line with open triangles, ethanol – closed squares, acetate – closed circles) and growth
properties (OD – dashed line with closed diamonds) of strains engineered for production of lactic acid. Glucose concentration is plotted on the secondary y axis. Upper charts
represent CEN.PK derived strains. Lower charts represent Ethanol Red derived strains. Genotypes of the strains are in the left corner of each chart, PTEF1-ldhL pdc1Δ pdc5Δ
represents strains containing ldhL gene inserted in chromosome X and non-sense mutations in PDC1 and PDC5 genes, PTEF1-ldhL: : pdc1Δ PTEF1-ldhL: : pdc5Δ represents strains
with disruption of PDC1 and PDC5 by PTEF1-ldhL expression cassette. Samples from three biological replicates were taken at marked time points. Error bars represent standard
deviation (SD, N¼3).
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glucose consumption was also slower. In 100 h 5.170.65 g/l of
glucose was consumed, while 2.570.3 g/l lactate was secreted (i.e.
yield of 0.4970.03 g lactic acid per 1 g glucose) (Fig. 4B).
4. Conclusions
In this study, we demonstrated the suitability of CRISPR–Cas9
for genetic manipulation of unrelated prototrophic polyploid
industrial yeast strains. CRISPR–Cas9 allowed highly efﬁcient
single-step gene disruption in diploid industrial strains. We also
illustrated that Cas9-mediated gene targeting can be combined
with simultaneous gene knock-in into the target site in all tested
strains. Decreased expression of Cas9 and increasing the amount
of a gRNA vector and a DNA repair template is beneﬁcial towards
increasing disruption efﬁciency and overall yield of positive
transformants. Moreover, we showed the simultaneous inactiva-
tion of two conditionally essential genes (PDC1 and PDC5), each
present in two alleles, in the industrial Ethanol Red strain. When
Cas9 and gRNA are introduced on episomal vectors, the latter can
be cured from the yeast, effectively resulting in marker-free
permanent modiﬁcation. The described CRISPR–Cas9 method is
easily applicable and universal tool, which can be quickly adapted
and tested for any genome editing change in a S. cerevisiae strain of
choice and greatly facilitates the metabolic engineering of indus-
trial strains.
Acknowledgments
This work is part of the BioREFINE-2G Project, which is co-
funded by the European Commission in the 7th Framework
Programme (Project no. FP7-613771). The authors acknowledge
the Novo Nordisk Foundation for ﬁnancial support. The authors
thank Tadas Jakočiu̅nas and Michael Krogh Jensen for valuable
advice and discussions, Laura Dato for help with FACS analysis,
Tomas Strucko for help with tetrad dissection, and Mette Kristen-
sen and Anders Holmgaard Hansen for HPLC assistance.
Appendix A. Supplementary materials
Supplementary data associated with this article can be found in
the online version at http://dx.doi.org/10.1016/j.meteno.2015.03.
001.
References
Achilli, A., Matmati, N., Casalone, E., Morpurgo, G., Lucaccioni, A., Pavlov, Y.I.,
Babudri, N., 2004. The exceptionally high rate of spontaneous mutations in the
polymerase delta proofreading exonuclease-deﬁcient Saccharomyces cerevisiae
strain starved for adenine. BMC Genet. 5, 7429–7437. http://dx.doi.org/10.1186/
1471-2156-5-34.
Bao, Z., Xiao, H., Liang, J., Zhang, L., Xiong, X., Sun, N., Si, T., Zhao, H., 2014.
Homology-Integrated CRISPR–Cas (HI-CRISPR) system for one-step multigene
disruption in Saccharomyces cerevisiae. ACS Synth. Biol. 41 (15), http://dx.doi.
org/10.1021/sb500255k.
Bikard, D., Jiang, W., Samai, P., Hochschild, A., Zhang, F., Marrafﬁni, L.A., 2013.
Programmable repression and activation of bacterial gene expression using an
engineered CRISPR–Cas system. Nucleic Acids Res. 41 (15), 7429–7437. http://dx.doi.
org/10.1093/nar/gkt520.
Borodina, I., Kildegaard, K.R., Jensen, N.B., Blicher, T.H., Maury, J., Sherstyk, S.,
Schneider, K., Lamosa, P., Herrgård, M.J., Rosenstand, I., Öberg, F., Forster, J.,
Nielsen, J., 2015. Establishing a synthetic pathway for high-level production of
3-hydroxypropionic acid in Saccharomyces cerevisiae via β-alanine. Metab. Eng.
27, 57–64. http://dx.doi.org/10.1016/j.ymben.2014.10.003.
Borodina, I., Nielsen, J., 2014. Advances in metabolic engineering of yeast Sacchar-
omyces cerevisiae for production of chemicals. Biotechnol. J. 9, 609–620. http:
//dx.doi.org/10.1002/biot.201300445.
Branduardi, P., Sauer, M., Gioia, L.D., Zampella, G., Valli, M., Mattanovich, D., Porro,
D., 2006. Lactate production yield from engineered yeasts is dependent from
the host background, the lactate dehydrogenase source and the lactate export.
Microb. Cell Factories 5, 4. http://dx.doi.org/10.1186/1475-2859-5-4.
Canelas, A.B., Harrison, N., Fazio, A., Zhang, J., Pitkänen, J.-P., van den Brink, J.,
Bakker, B.M., Bogner, L., Bouwman, J., Castrillo, J.I., Cankorur, A., Chumnanpuen,
P., Daran-Lapujade, P., Dikicioglu, D., van Eunen, K., Ewald, J.C., Heijnen, J.J.,
Kirdar, B., Mattila, I., Mensonides, F.I.C., Niebel, A., Penttilä, M., Pronk, J.T., Reuss,
M., Salusjärvi, L., Sauer, U., Sherman, D., Siemann-Herzberg, M., Westerhoff, H.,
de Winde, J., Petranovic, D., Oliver, S.G., Workman, C.T., Zamboni, N., Nielsen, J.,
2010. Integrated multilaboratory systems biology reveals differences in protein
metabolism between two reference yeast strains. Nat. Commun. 1, 145. http:
//dx.doi.org/10.1038/ncomms1150.
Cho, S.W., Kim, S., Kim, Y., Kweon, J., Kim, H.S., Bae, S., Kim, J.-S., 2013. Analysis of
off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and
nickases. Genome Res. 24 (1), 132–141. http://dx.doi.org/10.1101/gr.162339.113.
Cong, L., Ran, F.A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P.D., Wu, X., Jiang, W.,
Marrafﬁni, L.A., Zhang, F., 2013. Multiplex genome engineering using CRISPR/
Cas systems. Science 339, 819–823. http://dx.doi.org/10.1126/science.1231143.
Daley, J.M., Palmbos, P.L., Wu, D., Wilson, T.E., 2005. Nonhomologous end joining in
yeast. Annu. Rev. Genet. 39, 431–451. http://dx.doi.org/10.1146/annurev.
genet.39.073003.113340.
Daran-Lapujade, P., Daran, J.M., Kötter, P., Petit, T., Piper, M.D.W., Pronk, J.T., 2003.
Comparative genotyping of the Saccharomyces cerevisiae laboratory strains
S288C and CEN.PK113-7D using oligonucleotide microarrays. FEMS Yeast Res.
4, 259–269.
Demeke, M.M., Dietz, H., Li, Y., Foulquie-Moreno, M.R., Mutturi, S., Deprez, S., Den
Abt, T., Bonini, B.M., Liden, G., Dumortier, F., Verplaetse, A., Boles, E., Thevelein,
J.M., 2013. Development of a D-xylose fermenting and inhibitor tolerant
industrial Saccharomyces cerevisiae strain with high performance in lignocellu-
lose hydrolysates using metabolic and evolutionary engineering. Biotechnol.
Biofuels 6, 89. http://dx.doi.org/10.1186/1754-6834-6-89.
DiCarlo, J.E., Norville, J.E., Mali, P., Rios, X., Aach, J., Church, G.M., 2013. Genome
engineering in Saccharomyces cerevisiae using CRISPR–Cas systems. Nucleic
Acids Res. , http://dx.doi.org/10.1093/nar/gkt135.
Dickinson, D.J., Ward, J.D., Reiner, D.J., Goldstein, B., 2013. Engineering the
Caenorhabditis elegans genome using Cas9-triggered homologous recombina-
tion. Nat. Methods 10, 1028–1034. http://dx.doi.org/10.1038/nmeth.2641.
Flikweert, M.T., Van Der Zanden, L., Janssen, W.M., Steensma, H.Y., Van Dijken, J.P.,
Pronk, J.T., 1996. Pyruvate decarboxylase: an indispensable enzyme for growth
of Saccharomyces cerevisiae on glucose. Yeast 12, 247–257. http://dx.doi.org/
10.1002/(SICI)1097-0061(19960315)12:3o247::AID-YEA91143.0.CO;2-I.
Fu, Y., Foden, J.A., Khayter, C., Maeder, M.L., Reyon, D., Joung, J.K., Sander, J.D., 2013.
High-frequency off-target mutagenesis induced by CRISPR–Cas nucleases in
human cells. Nat. Biotechnol. 31, 822–826. http://dx.doi.org/10.1038/nbt.2623.
Gasiunas, G., Barrangou, R., Horvath, P., Siksnys, V., 2012. Cas9–crRNA ribonucleo-
protein complex mediates speciﬁc DNA cleavage for adaptive immunity in
bacteria. Proc. Natl. Acad. Sci. U. S. A. 109, 2579–2586. http://dx.doi.org/10.1073/
pnas.1208507109.
Gietz, R.D., Woods, R.A., 2006. Yeast transformation by the LiAc/SS carrier DNA/PEG
method. Methods Mol. Biol. 313, 107–120. http://dx.doi.org/10.1385/1-59259-
958-3:107.
Gratz, S.J., Cummings, A.M., Nguyen, J.N., Hamm, D.C., Donohue, L.K., Harrison, M.
M., Wildonger, J., O'Connor-Giles, K.M., 2013. Genome engineering of Drosophila
with the CRISPR RNA-guided Cas9 nuclease. Genetics 194 (4), 1029–1035. http:
//dx.doi.org/10.1534/genetics.113.152710.
Guldener, U., Heck, S., Fielder, T., Beinhauer, J., Hegemann, J.H., 1996. A new efﬁcient
gene disruption cassette for repeated use in budding yeast. Nucleic Acids Res.
24, 2519–2524.
Horvath, P., Barrangou, R., 2010. CRISPR/Cas, the immune system of bacteria and
archaea. Science 327, 167–170. http://dx.doi.org/10.1126/science.1179555.
Hsu, P.D., Scott, D.A., Weinstein, J.A., Ran, F.A., Konermann, S., Agarwala, V., Li, Y.,
Fine, E.J., Wu, X., Shalem, O., Cradick, T.J., Marrafﬁni, L.A., Bao, G., Zhang, F., 2013.
DNA targeting speciﬁcity of RNA-guided Cas9 nucleases. Nat. Biotechnol. 31,
827–832. http://dx.doi.org/10.1038/nbt.2647.
Ishida, N., Saitoh, S., Onishi, T., Tokuhiro, K., Nagamori, E., Kitamoto, K., Takahashi, H.,
2006. The effect of pyruvate decarboxylase gene knockout in Saccharo-
myces cerevisiae on L-lactic acid production. Biosci. Biotechnol. Biochem. 70,
1148–1153.
Jakočiūnas, T., Bonde, I., Herrgård, M., Harrison, S.J., Kristensen, M., Pedersen, L.E.,
Jensen, M.K., Keasling, J.D., 2015. Multiplex metabolic pathway engineering
using CRISPR/Cas9 in Saccharomyces cerevisiae. Metab. Eng. 28, 213–222. http:
//dx.doi.org/10.1016/j.ymben.2015.01.008.
Jensen, N.B., Strucko, T., Kildegaard, K.R., David, F., Maury, J., Mortensen, U.H.,
Forster, J., Nielsen, J., Borodina, I., 2014. EasyClone: method for iterative
chromosomal integration of multiple genes in Saccharomyces cerevisiae. FEMS
Yeast Res. 14, 238–248. http://dx.doi.org/10.1111/1567-1364.12118.
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J.A., Charpentier, E., 2012. A
programmable dual-RNA-guided DNA endonuclease in adaptive bacterial
immunity. Science 337, 816–821. http://dx.doi.org/10.1126/science.1225829.
Le Borgne, S., 2012. Genetic engineering of industrial strains of Saccharomyces
cerevisiae. Methods Mol. Biol. 824, 451–465. http://dx.doi.org/10.1007/978-1-
61779-433-9_24.
Li, M., Borodina, I., 2015. Application of synthetic biology for production of
chemicals in yeast S. cerevisiae. FEMS Yeast Res. 15, 1–12. http://dx.doi.org/
10.1111/1567-1364.12213.
Li, T., Huang, S., Zhao, X., Wright, D.A., Carpenter, S., Spalding, M.H., Weeks, D.P.,
Yang, B., 2011. Modularly assembled designer TAL effector nucleases for
V. Stovicek et al. / Metabolic Engineering Communications 2 (2015) 13–22 21
targeted gene knockout and gene replacement in eukaryotes. Nucleic Acids Res.
39, 6315–6325. http://dx.doi.org/10.1093/nar/gkr188.
Mali, P., Yang, L., Esvelt, K.M., Aach, J., Guell, M., DiCarlo, J.E., Norville, J.E., Church, G.
M., 2013. RNA-guided human genome engineering via Cas9. Science 339,
823–826. http://dx.doi.org/10.1126/science.1232033.
Nørholm, M.H., 2010. A mutant Pfu DNA polymerase designed for advanced uracil-
excision DNA engineering. BMC Biotechnol. 10, 21. http://dx.doi.org/10.1186/
1472-6750-10-21.
Nour-Eldin, H.H., Geu-Flores, F., Halkier, B.A., 2010. USER cloning and USER fusion:
the ideal cloning techniques for small and big laboratories. Methods Mol. Biol.
643, 185–200. http://dx.doi.org/10.1007/978-1-60761-723-5_13.
Porro, D., Brambilla, L., Ranzi, B.M., Martegani, E., Alberghina, L., 1995. Development
of metabolically engineered Saccharomyces cerevisiae cells for the production of
lactic acid. Biotechnol. Prog. 11, 294–298. http://dx.doi.org/10.1021/bp00033
a009.
Pronk, J.T., Yde Steensma, H., Van Dijken, J.P., 1996. Pyruvate metabolism in
Saccharomyces cerevisiae. Yeast 12, 1607–1633. http://dx.doi.org/10.1002/(SICI)
1097-0061(199612)12:163.0.CO;2-4.
Reid, R.J.D., Sunjevaric, I., Keddache, M., Rothstein, R., Kedacche, M., 2002. Efﬁcient
PCR-based gene disruption in Saccharomyces strains using intergenic primers.
Yeast 19, 319–328. http://dx.doi.org/10.1002/yea.817.
Ronda, C., Pedersen, L.E., Hansen, H.G., Kallehauge, T.B., Betenbaugh, M.J., Nielsen, A.
T., Kildegaard, H.F., 2014. Accelerating genome editing in CHO cells using
CRISPR Cas9 and CRISPy, a web-based target ﬁnding tool. Biotechnol. Bioeng.
111, 1604–1616. http://dx.doi.org/10.1002/bit.25233.
Ryan, O.W., Skerker, J.M., Maurer, M.J., Li, X., Tsai, J.C., Poddar, S., Lee, M.E.,
DeLoache, W., Dueber, J.E., Arkin, A.P., Cate, J.H., 2014. Selection of chromosomal
DNA libraries using a multiplex CRISPR system. eLife 3, http://dx.doi.org/
10.7554/eLife.03703.
Solis-Escalante, D., Kuijpers, N.G.A., Bongaerts, N., Bolat, I., Bosman, L., Pronk, J.T.,
Daran, J.-M., Daran-Lapujade, P., 2013. amdSYM, a new dominant recyclable
marker cassette for Saccharomyces cerevisiae. FEMS Yeast Res. 13, 126–139.
http://dx.doi.org/10.1111/1567-1364.12024.
Toddo, S., Söderström, B., Palombo, I., von Heijne, G., Nørholm, M.H.H., Daley, D.O.,
2012. Application of split-green ﬂuorescent protein for topology mapping
membrane proteins in Escherichia coli. Protein Sci. 21, 1571–1576. http://dx.
doi.org/10.1002/pro.2131.
Ugolini, S., Bruschi, C.V., 1996. The red/white colony color assay in the yeast
Saccharomyces cerevisiae: epistatic growth advantage of white ade8-18, ade2
cells over red ade2 cells. Curr. Genet. 30, 485–492.
Urnov, F.D., Rebar, E.J., Holmes, M.C., Zhang, H.S., Gregory, P.D., 2010. Genome
editing with engineered zinc ﬁnger nucleases. Nat. Rev. Genet. 11, 636–646.
http://dx.doi.org/10.1038/nrg2842.
Van Maris A.J.A., Pronk J.T., Van Dijken J.P, 2004a. Pyruvate Producing Yeast Strain.
WO/2004/099425.
Van Maris, A.J.A., Winkler, A.A., Porro, D., Dijken, J.P., Pronk, J.T., 2004b. Homo-
fermentative lactate production cannot sustain anaerobic growth of engineered
Saccharomyces cerevisiae: possible consequence of energy-dependent lactate
export. Appl. Environ. Microbiol. 70, 2898–2905. http://dx.doi.org/10.1128/
AEM.70.5.2898-2905.2004.
Wach, A., Brachat, A., Pöhlmann, R., Philippsen, P., 1994. New heterologous modules
for classical or PCR-based gene disruptions in Saccharomyces cerevisiae. Yeast
10, 1793–1808.
Yon, J., Fried, M., 1989. Precise gene fusion by PCR. Nucleic Acids Res. 17, 4895. http:
//dx.doi.org/10.1093/nar/17.12.4895.
V. Stovicek et al. / Metabolic Engineering Communications 2 (2015) 13–2222
